DRCT Fundamental Analysis - DIRECT DIGITAL HOLDINGS IN-A

Fundamental Rating

Overall DRCT gets a fundamental rating of 1 out of 10. We evaluated DRCT against 94 industry peers in the Media industry. DRCT may be in some trouble as it scores bad on both profitability and health. DRCT has a expensive valuation and it also scores bad on growth.

Quickly go to:

1. Profitability

1.1 Basic Checks

In the past year DRCT has reported negative net income.

DRCT had a negative operating cash flow in the past year.

In the past 5 years DRCT reported 4 times negative net income.

In multiple years DRCT reported negative operating cash flow during the last 5 years.

1.2 Ratios

With a Return On Assets value of -42.00%, DRCT is not doing good in the industry: 81.91% of the companies in the same industry are doing better.

		Industry Rank	Sector Rank
ROA	-42%
ROE	N/A
ROIC	N/A

ROA(3y)-6.66%

ROA(5y)-5.43%

ROE(3y)N/A

ROE(5y)N/A

ROIC(3y)N/A

ROIC(5y)N/A

1.3 Margins

DRCT's Gross Margin of 31.43% is on the low side compared to the rest of the industry. DRCT is outperformed by 60.64% of its industry peers.

DRCT's Gross Margin has declined in the last couple of years.

DRCT does not have Profit Margin and Operating Margin available, so we won't be analyzing them here.

		Industry Rank	Sector Rank
OM	N/A
PM (TTM)	N/A
GM	31.43%

OM growth 3YN/A

OM growth 5YN/A

PM growth 3YN/A

PM growth 5YN/A

GM growth 3Y-16.71%

GM growth 5YN/A

More info and screens

ROA

ROE

ROIC

Operating and Profit Margin

Show most profitable peers

2. Health

2.1 Basic Checks

DRCT does not have a ROIC to compare to the WACC, probably because it is not profitable.

DRCT has more shares outstanding than it did 1 year ago.

The debt/assets ratio for DRCT is higher compared to a year ago.

2.2 Solvency

Based on the Altman-Z score of -2.14, we must say that DRCT is in the distress zone and has some risk of bankruptcy.

DRCT has a worse Altman-Z score (-2.14) than 76.60% of its industry peers.

		Industry Rank	Sector Rank
Debt/Equity	N/A
Debt/FCF	N/A
Altman-Z	-2.14

ROIC/WACCN/A

WACC10.82%

2.3 Liquidity

DRCT has a Current Ratio of 0.37. This is a bad value and indicates that DRCT is not financially healthy enough and could expect problems in meeting its short term obligations.

With a Current ratio value of 0.37, DRCT is not doing good in the industry: 88.30% of the companies in the same industry are doing better.

A Quick Ratio of 0.37 indicates that DRCT may have some problems paying its short term obligations.

With a Quick ratio value of 0.37, DRCT is not doing good in the industry: 88.30% of the companies in the same industry are doing better.

		Industry Rank	Sector Rank
Current Ratio	0.37
Quick Ratio	0.37

More info and screens

WACC

Debt/Equity

How to determine the health of a company

Altman-Z score

Show peers with great health

3. Growth

3.1 Past

The Earnings Per Share has grown by an impressive 49.65% over the past year.

DRCT shows a very negative growth in Revenue. In the last year, the Revenue has decreased by -62.46%.

DRCT shows quite a strong growth in Revenue. Measured over the last years, the Revenue has been growing by 17.76% yearly.

EPS 1Y (TTM)49.65%

EPS 3YN/A

EPS 5YN/A

EPS Q2Q%88.46%

Revenue 1Y (TTM)-62.46%

Revenue growth 3Y17.76%

Revenue growth 5YN/A

Sales Q2Q%-12.02%

3.2 Future

DRCT is expected to show a strong growth in Earnings Per Share. In the coming years, the EPS will grow by 41.30% yearly.

Based on estimates for the next years, DRCT will show a very negative growth in Revenue. The Revenue will decrease by -10.39% on average per year.

EPS Next Y68.01%

EPS Next 2Y41.3%

EPS Next 3YN/A

EPS Next 5YN/A

Revenue Next Year-35.97%

Revenue Next 2Y-10.39%

Revenue Next 3YN/A

Revenue Next 5YN/A

3.3 Evolution

The Revenue growth rate is decreasing: in the next years the growth will be less than in the last years.

More info and screens

Find the best growth stocks

Show best growing peers

4. Valuation

4.1 Price/Earnings Ratio

The Price/Earnings Ratio is negative for DRCT. In the last year negative earnings were reported.

Besides the negative Price/Earnings Ratio, also the Forward Price/Earnings Ratio is negative for DRCT. No positive earnings are expected for the next year.

		Industry Rank	Sector Rank
PE	N/A
Fwd PE	N/A

4.2 Price Multiples

		Industry Rank	Sector Rank
P/FCF	N/A
EV/EBITDA	N/A

4.3 Compensation for Growth

DRCT's earnings are expected to grow with 41.30% in the coming years. This may justify a more expensive valuation.

PEG (NY)N/A

PEG (5Y)N/A

EPS Next 2Y41.3%

EPS Next 3YN/A

More info and screens

Show best valued peers

5. Dividend

5.1 Amount

No dividends for DRCT!.

		Industry Rank	Sector Rank
Dividend Yield	N/A

More info and screens

Find the best dividend stocks

Show peers with best dividend

DIRECT DIGITAL HOLDINGS IN-A

NASDAQ:DRCT (12/9/2025, 8:00:02 PM)

Premarket: 0.0885 0 (-3.8%)

0.092

+0 (+3.14%)

Chartmill FA Rating

GICS SectorCommunication Services

GICS IndustryGroupMedia & Entertainment

GICS IndustryMedia

Earnings (Last)11-06 2025-11-06/amc

Earnings (Next)03-25 2026-03-25/amc

Inst Owners1.53%

Inst Owner Change-28.5%

Ins Owners1.48%

Ins Owner Change16.87%

Market Cap2.77M

Revenue(TTM)35.37M

Net Income(TTM)-9.46M

Analysts80

Price Target2.04 (2117.39%)

Short Float %21.26%

Short Ratio0.33

Dividend

		Industry Rank	Sector Rank
Dividend Yield	N/A

Yearly DividendN/A

Dividend Growth(5Y)N/A

DPN/A

Div Incr Years0

Div Non Decr Years0

Ex-DateN/A

Surprises & Revisions

EPS beat(2)1

Avg EPS beat(2)-707.56%

Min EPS beat(2)-1468.63%

Max EPS beat(2)53.51%

EPS beat(4)1

Avg EPS beat(4)-2044.59%

Min EPS beat(4)-6762.75%

Max EPS beat(4)53.51%

EPS beat(8)1

Avg EPS beat(8)-1272.49%

EPS beat(12)2

Avg EPS beat(12)-831.71%

EPS beat(16)5

Avg EPS beat(16)-613.34%

Revenue beat(2)0

Avg Revenue beat(2)-40.4%

Min Revenue beat(2)-64.81%

Max Revenue beat(2)-15.98%

Revenue beat(4)0

Avg Revenue beat(4)-32.8%

Min Revenue beat(4)-64.81%

Max Revenue beat(4)-14.88%

Revenue beat(8)0

Avg Revenue beat(8)-38.81%

Revenue beat(12)4

Avg Revenue beat(12)-16.24%

Revenue beat(16)6

Avg Revenue beat(16)-7.36%

PT rev (1m)-66.67%

PT rev (3m)-66.67%

EPS NQ rev (1m)-633.33%

EPS NQ rev (3m)-633.33%

EPS NY rev (1m)-160.87%

EPS NY rev (3m)-160.87%

Revenue NQ rev (1m)-55.84%

Revenue NQ rev (3m)-55.84%

Revenue NY rev (1m)-39.84%

Revenue NY rev (3m)-39.84%

Valuation

		Industry Rank	Sector Rank
PE	N/A
Fwd PE	N/A
P/S	0.08
P/FCF	N/A
P/OCF	N/A
P/B	N/A
P/tB	N/A
EV/EBITDA	N/A

EPS(TTM)-1.23

EYN/A

EPS(NY)-0.01

Fwd EYN/A

FCF(TTM)-0.29

FCFYN/A

OCF(TTM)-0.29

OCFYN/A

SpS1.18

BVpS-0.04

TBVpS-0.53

PEG (NY)N/A

PEG (5Y)N/A

Graham NumberN/A

Profitability

		Industry Rank	Sector Rank
ROA	-42%
ROE	N/A
ROCE	N/A
ROIC	N/A
ROICexc	N/A
ROICexgc	N/A
OM	N/A
PM (TTM)	N/A
GM	31.43%
FCFM	N/A

ROA(3y)-6.66%

ROA(5y)-5.43%

ROE(3y)N/A

ROE(5y)N/A

ROIC(3y)N/A

ROIC(5y)N/A

ROICexc(3y)N/A

ROICexc(5y)N/A

ROICexgc(3y)N/A

ROICexgc(5y)N/A

ROCE(3y)N/A

ROCE(5y)N/A

ROICexgc growth 3YN/A

ROICexgc growth 5YN/A

ROICexc growth 3YN/A

ROICexc growth 5YN/A

OM growth 3YN/A

OM growth 5YN/A

PM growth 3YN/A

PM growth 5YN/A

GM growth 3Y-16.71%

GM growth 5YN/A

F-Score3

Asset Turnover1.57

Health

		Industry Rank	Sector Rank
Debt/Equity	N/A
Debt/FCF	N/A
Debt/EBITDA	N/A
Cap/Depr	1.7%
Cap/Sales	0.11%
Interest Coverage	N/A
Cash Conversion	N/A
Profit Quality	N/A
Current Ratio	0.37
Quick Ratio	0.37
Altman-Z	-2.14

F-Score3

WACC10.82%

ROIC/WACCN/A

Cap/Depr(3y)14.5%

Cap/Depr(5y)N/A

Cap/Sales(3y)0.3%

Cap/Sales(5y)N/A

Profit Quality(3y)N/A

Profit Quality(5y)N/A

High Growth Momentum

Growth

EPS 1Y (TTM)49.65%

EPS 3YN/A

EPS 5YN/A

EPS Q2Q%88.46%

EPS Next Y68.01%

EPS Next 2Y41.3%

EPS Next 3YN/A

EPS Next 5YN/A

Revenue 1Y (TTM)-62.46%

Revenue growth 3Y17.76%

Revenue growth 5YN/A

Sales Q2Q%-12.02%

Revenue Next Year-35.97%

Revenue Next 2Y-10.39%

Revenue Next 3YN/A

Revenue Next 5YN/A

EBIT growth 1Y13.66%

EBIT growth 3YN/A

EBIT growth 5YN/A

EBIT Next Year50.13%

EBIT Next 3YN/A

EBIT Next 5YN/A

FCF growth 1Y-435.56%

FCF growth 3YN/A

FCF growth 5YN/A

OCF growth 1Y-352.53%

OCF growth 3YN/A

OCF growth 5YN/A

DIRECT DIGITAL HOLDINGS IN-A / DRCT FAQ

What is the fundamental rating for DRCT stock?

ChartMill assigns a fundamental rating of 1 / 10 to DRCT.

Can you provide the valuation status for DIRECT DIGITAL HOLDINGS IN-A?

ChartMill assigns a valuation rating of 1 / 10 to DIRECT DIGITAL HOLDINGS IN-A (DRCT). This can be considered as Overvalued.

What is the profitability of DRCT stock?

DIRECT DIGITAL HOLDINGS IN-A (DRCT) has a profitability rating of 0 / 10.

Can you provide the expected EPS growth for DRCT stock?

The Earnings per Share (EPS) of DIRECT DIGITAL HOLDINGS IN-A (DRCT) is expected to grow by 68.01% in the next year.

DIRECT DIGITAL HOLDINGS IN-A (DRCT) Stock Fundamental Analysis

1. Profitability

1.1 Basic Checks

1.2 Ratios

1.3 Margins

More info and screens

2. Health

2.1 Basic Checks

2.2 Solvency

2.3 Liquidity

More info and screens

3. Growth

3.1 Past

3.2 Future

3.3 Evolution

More info and screens

4. Valuation

4.1 Price/Earnings Ratio

4.2 Price Multiples

4.3 Compensation for Growth

More info and screens

5. Dividend

5.1 Amount

More info and screens

DIRECT DIGITAL HOLDINGS IN-A / DRCT FAQ

What is the fundamental rating for DRCT stock?

Can you provide the valuation status for DIRECT DIGITAL HOLDINGS IN-A?

What is the profitability of DRCT stock?

Can you provide the expected EPS growth for DRCT stock?